NABP Compounding Pharmacy Accreditation vs. Alternatives
Comparing NABP, PCAB, and State Licensure for Compounding Pharmacy Quality Credentialing
Compounding pharmacies evaluating quality credentials encounter several options. This comparison helps 503A and 503B compounders understand the differences between NABP Compounding Pharmacy Accreditation and the alternatives, and when each is the right choice.
Side-by-Side Comparison
| Dimension | NABP Compounding Pharmacy Accreditation | PCAB (Pharmacy Compounding Accreditation Board) | State Pharmacy Licensure | FDA Registration (503B) |
|---|---|---|---|---|
| Who issues it | NABP (national pharmacy regulatory body) | PCAB (accreditation arm of ACHC) | State board of pharmacy | FDA (for 503B outsourcing facilities) |
| Covers 503A compounders | Yes | Yes | Yes (license required) | No — 503A pharmacies are not registered with FDA |
| Covers 503B outsourcing facilities | Yes | Yes | Yes (license required) | Yes — required registration |
| On-site inspection required | Yes — prerequisite VPP inspection | Yes — on-site accreditation survey | State inspection (varies) | Yes — FDA conducts CGMP inspections of 503B facilities |
| USP compliance evaluated | Yes — USP 795/797/800 as applicable | Yes — USP 795/797/800 as applicable | Varies by state | No — FDA evaluates CGMP, not USP specifically |
| Market recognition | High — NABP is the national pharmacy regulatory association | High — PCAB/ACHC is well-recognized in compounding | Required baseline — not a differentiator | Required for 503B — not a market differentiator beyond legal compliance |
| Health system/prescriber recognition | Strong — NABP name recognition with health system pharmacies | Strong — PCAB widely recognized by prescribers and health systems | Minimal beyond licensure verification | Recognized for 503B purchasing decisions |
| Mandatory vs. voluntary | Voluntary | Voluntary | Mandatory | Mandatory for 503B operations |
NABP vs. PCAB for Compounding Pharmacy Accreditation
PCAB (Pharmacy Compounding Accreditation Board), now operating as an accreditation arm of ACHC, is the other major national compounding pharmacy accreditation program and has historically been the more recognized credential specifically within the compounding pharmacy community. Many independent compounding pharmacies, hormone therapy specialists, and veterinary compounders have pursued PCAB accreditation as their primary quality credential.
Both NABP and PCAB evaluate USP compliance and compounding quality through on-site inspection and documentation review. The choice between them often comes down to existing relationships and the specific market the pharmacy serves. Pharmacies with existing ACHC relationships may find PCAB a natural extension. Pharmacies that want the broadest possible name recognition with state boards of pharmacy and health system pharmacy departments may find NABP's regulatory body affiliation more compelling. IHS is qualified to advise on and support both programs.
Compounding Pharmacy Accreditation vs. State Licensure
State pharmacy licensure is the legal baseline for all compounding pharmacies. Most state boards of pharmacy require compounding pharmacies to comply with USP standards as a condition of licensure, but the depth of inspection and documentation evaluation in state licensing typically falls well short of what NABP or PCAB accreditation requires. Accreditation provides an independent, nationally standardized quality verification that supplements — and significantly exceeds — the quality assurance provided by state licensure.
Special Considerations for 503B Outsourcing Facilities
503B outsourcing facilities are subject to FDA CGMP inspections and must maintain FDA registration as a condition of operation. FDA registration is not an accreditation — it is a legal prerequisite. NABP Compounding Pharmacy Accreditation provides a separate quality credential that demonstrates to hospital and health system purchasers that the 503B facility meets a national quality standard beyond what FDA registration alone communicates. Many hospital systems have begun requiring or preferring accredited 503B suppliers as a condition of purchasing contracts.
Not Sure Which Compounding Accreditation Is Right for Your Pharmacy?
IHS provides accreditor-neutral advisory on the right compounding pharmacy quality credentialing strategy for your specific compounding operations, market, and client relationships. Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — leads every engagement.
Schedule a Free Discovery Session